A new research team found that resiquimod enhances immunological response in human neuroblastoma cell cultures via TLR7-NFκB-C-C motif chemokine ligand 2 signaling, providing a novel possible therapy approach for neurotropism due to viruses (Kaizuka et al., 2024). Here, NFKB1 is linked to neuroblastoma.